Specialty code 174400000X · Santa Barbara, CA
NPI
1164549242
Since 2007
Specialty
Specialty code 174400000X
Code 174400000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
350 S Hope Ave, Suite A102
Santa Barbara, CA, 93105
Phone (805) 563-0003
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$185K
1,528 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Diana L Schwarzbein prescribed most often to Medicare patients was Vivelle-Dot (Estradiol), with 338 prescriptions and refills. In total Diana L Schwarzbein wrote 1,528 Medicare prescriptions that cost $185K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-06-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Vivelle-Dot Estradiol | 338 | 604 | 60 | $111K |
| Hydrocortisone Generic | 148 | 303 | 53 | $4,023 |
| Levothyroxine Sodium Generic | 113 | 302 | 30 | $1,081 |
| Dotti Estradiol | 106 | 120 | 18 | $7,498 |
| Synthroid Levothyroxine Sodium | 103 | 242 | 24 | $8,369 |
| Trazodone Hcl Generic | 100 | 226 | 25 | $969 |
| Atomoxetine Hcl Generic | 76 | 92 | 29 | $8,025 |
| Liothyronine Sodium Generic | 66 | 193 | 25 | $2,194 |
| Bupropion Hcl Generic | 49 | 89 | 12 | $826 |
| Armour Thyroid Thyroid,pork | 33 | 67 | Under 11 | $1,599 |
| Tirosint Levothyroxine Sodium | 32 | 48 | Under 11 | $5,398 |
| Estradiol (Twice Weekly) Estradiol | 30 | 56 | Under 11 | $3,352 |
| Duloxetine Hcl Generic | 26 | 44 | Under 11 | $385 |
| Metformin Hcl Er Metformin Hcl | 26 | 78 | 11 | $237 |
| Colesevelam Hcl Generic | 25 | 57 | 12 | $6,379 |
Brand drugs: 639 claims; generic drugs: 820 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Diana L Schwarzbein were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.